NIH Panel Recommends Restrictions on Employee Consulting Deals with Industry: LA Times | GenomeWeb

NEW YORK, April 9 (GenomeWeb News) -A National Institutes of Health blue ribbon panel has in a draft report called on the NIH to prohibit its employees from accepting stock or stock options from private companies, and to publicly disclose all payments to employees by drug companies, the Los Angeles Times reported today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.